Biotechnology: Pharmaceutical Preparations Stocks
436 biotechnology: pharmaceutical preparations stocks ranked by market capitalization, page 8 of 9. Updated October 11, 2026.
Today
+1.28%Biotechnology: Pharmaceutical Preparations stocks ranked 351–400
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 351 | IXHL | Incannex Healthcare Inc. | 3.10 | -3.13% | 43.80K | $38.89M |
| 352 | LITS | Lite Strategy Inc. | 1.27 | +4.10% | 539.93K | $38.62M |
| 353 | IBO | Impact BioMedical Inc. | 4.25 | +3.41% | 3.99K | $36.31M |
| 354 | GRDX | GridAI Technologies Corp. | 4.97 | +3.54% | 100.68K | $35.44M |
| 355 | ATNM | Actinium Pharmaceuticals Inc. (Delaware) | 1.10 | +1.85% | 105.76K | $34.59M |
| 356 | BCTX | BriaCell Therapeutics Corp. | 3.91 | -0.13% | 23.32K | $34.02M |
| 357 | NNVC | NanoViricides Inc. | 1.30 | -0.76% | 169.52K | $33.18M |
| 358 | NXTC | NextCure Inc. | 7.18 | +5.90% | 85.75K | $32.87M |
| 359 | RMTI | Rockwell Medical Inc. | 7.89 | -1.62% | 8.00K | $31.80M |
| 360 | RNAZ | TransCode Therapeutics Inc. | 1.86 | +8.77% | 84.08K | $31.49M |
| 361 | MCRB | Seres Therapeutics Inc. | 2.71 | +3.04% | 79.41K | $27.22M |
| 362 | IMMP | Immutep Limited ADR | 3.63 | -5.47% | 22.93K | $26.75M |
| 363 | ABVC | ABVC BioPharma Inc. | 1.00 | +2.04% | 41.47K | $26.69M |
| 364 | SHPH | Shuttle Pharmaceuticals Holdings Inc. | 5.33 | -4.05% | 29.45K | $25.40M |
| 365 | KYNB | Kyntra Bio Inc. | 6.11 | +2.52% | 6.34K | $24.74M |
| 366 | ATOS | Atossa Therapeutics Inc. | 2.44 | +0.83% | 265.61K | $24.35M |
| 367 | TXMD | TherapeuticsMD Inc. | 2.06 | +2.49% | 10.05K | $23.84M |
| 368 | OPTH | Optimi Health Corp. | 4.02 | -1.59% | 21.04K | $23.02M |
| 369 | AYTU | Aytu BioPharma Inc. | 2.03 | -1.22% | 10.53K | $22.01M |
| 370 | QNRX | Quoin Pharmaceuticals Ltd. ADR | 4.50 | -1.10% | 42.58K | $21.62M |
| 371 | UPC | Universe Pharmaceuticals Inc. Class A | 4.15 | 0.00% | 11.94K | $20.85M |
| 372 | COCP | Cocrystal Pharma Inc. | 1.07 | 0.00% | 4.26K | $20.61M |
| 373 | AKTX | Akari Therapeutics plc ADS | 8.77 | +3.30% | 76.45K | $20.04M |
| 374 | QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | 2.94 | -5.47% | 130.00K | $18.90M |
| 375 | NEUP | Neuphoria Therapeutics Inc. | 3.36 | +0.30% | 2.48K | $18.18M |
| 376 | NCEL | NewcelX Ltd. | 3.05 | -2.09% | 1.30K | $17.59M |
| 377 | RADX | Radiopharm Theranostics Limited ADR | 1.13 | +1.80% | 65.56K | $16.49M |
| 378 | PTN | Palatin Technologies Inc. | 8.60 | -4.55% | 31.44K | $15.32M |
| 379 | HIND | Vyome Holdings Inc. | 2.09 | +2.96% | 7.49K | $14.67M |
| 380 | LPCN | Lipocine Inc. | 1.72 | -10.88% | 1.06M | $14.18M |
| 381 | TVRD | Tvardi Therapeutics Inc. | 1.03 | -4.63% | 130.29K | $13.74M |
| 382 | CLRB | Cellectar Biosciences Inc. | 1.45 | +3.57% | 91.48K | $13.71M |
| 383 | BIVI | BioVie Inc. Class A | 1.39 | +8.59% | 204.86K | $12.07M |
| 384 | GTBP | GT Biopharma Inc. | 6.68 | +12.27% | 43.38K | $12.05M |
| 385 | ASBP | Aspire-Lakewood Holdings Inc. | 8.30 | 0.00% | 34.17K | $11.64M |
| 386 | LSTA | Lisata Therapeutics Inc. | 1.06 | -11.67% | 280.23K | $11.45M |
| 387 | KPRX | Kiora Pharmaceuticals Inc. | 2.54 | +0.40% | 4.46K | $11.24M |
| 388 | BLRX | BioLineRx Ltd. ADR | 2.22 | -0.18% | 9.63K | $11.03M |
| 389 | ADIL | Adial Pharmaceuticals Inc | 3.90 | -1.76% | 3.05K | $10.24M |
| 390 | CMMB | Chemomab Therapeutics Ltd. ADR | 1.38 | -0.72% | 12.20K | $10.11M |
| 391 | JAGX | Jaguar Health Inc. | 4.79 | +5.74% | 1.09M | $9.32M |
| 392 | MTVA | MetaVia Inc. | 1.41 | +5.22% | 51.05K | $9.29M |
| 393 | IMRN | Immuron Limited ADR | 1.08 | -2.70% | 10.64K | $8.72M |
| 394 | CALC | CalciMedica Inc. | 1.27 | -2.31% | 82.15K | $8.67M |
| 395 | CURX | Curanex Pharmaceuticals Inc | 5.31 | +11.55% | 17.09K | $8.33M |
| 396 | FBLG | FibroBiologics Inc. | 1.13 | +1.80% | 182.31K | $8.00M |
| 397 | BOLT | Bolt Biotherapeutics Inc. | 4.11 | +13.22% | 87.22K | $7.92M |
| 398 | LGVN | Longeveron Inc. Class A | 2.48 | +4.64% | 58.46K | $7.91M |
| 399 | CNSP | CNS Pharmaceuticals Inc. | 5.35 | 0.00% | 1.15K | $7.82M |
| 400 | APUS | Apimeds Pharmaceuticals US Inc. | 5.02 | -8.89% | 452.82K | $7.58M |
Explore more
Prices as of Oct 11, 3:20 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer